ARTV Artiva Biotherapeutics, Inc.
Healthcare$7.67-2.54%ClosedMarket Cap: $189.6M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
4
Dispositions
5
Buy/Sell Ratio
0.80
Net Shares
+8,937,514
Shares Acquired
8,990,554
Shares Disposed
53,040
Total Bought ($)
$2.00
Total Sold ($)
$5.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue May 19 | Raymon Heather | officer: SVP, Research and Development | Sell | 3,095 | $9.01 | 148,228 |
| Tue May 19 | Miralles Gines Diego | officer: President & Head of R&D | Sell | 232,500 | $9.22 | 232,500 |
| Tue May 19 | Miralles Gines Diego | officer: President & Head of R&D | Sell | 77,500 | $0.00 | 77,500 |
| Tue May 19 | Horan Christopher | officer: Chief Tech Operations Officer | Sell | 7,002 | $9.01 | 293,450 |
| Tue May 19 | Bush Jennifer | officer: COO, CLO, Compliance Officer | Sell | 8,790 | $9.01 | 337,920 |
| Tue May 19 | Banerjee Subhashis | officer: Chief Medical Officer | Sell | 7,037 | $9.01 | 144,963 |
| Tue May 19 | Aslan Fred | director, officer: Chief Executive Officer | Sell | 27,116 | $9.01 | 1,535,082 |
| Wed May 13 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 6,510,416 | $11.52 | 15,203,995 |
| Wed May 13 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | Buy | 2,170,138 | $0.00 | 2,170,138 |
| Tue Mar 10 | Huston Thad Allen | officer: Chief Financial Officer | Sell | 220,000 | $0.00 | 220,000 |
| Tue Feb 24 | Huston Thad Allen | Sell | 0 | $0.00 | 0 | |
| Thu Feb 19 | Sorg Elaine K. | director | Sell | 27,500 | $4.15 | 27,500 |
| Thu Feb 19 | Sorg Elaine K. | Sell | 0 | $0.00 | 0 | |
| Wed Feb 18 | Raymon Heather | officer: SVP, Research and Development | Sell | 1,521 | $4.00 | 151,323 |
| Wed Feb 18 | Raymon Heather | officer: SVP, Research and Development | Sell | 46,000 | $0.00 | 152,844 |